北京市核医学2019年基本情况调查分析

目的:全面了解北京市医疗机构核医学发展现状，为国家相关主管部门合理配置医疗资源和制定相关医疗政策提供参考数据。方法:采用问卷调查形式，对2019年北京市拥有核医学相关科室的医疗单位进行调查。调查问卷的发放采用现场当面呈送与电子邮件相结合的方式。调查内容包括医疗机构或科室的概况、业务设置、影像设备规模、科室人员、诊疗工作...

Investigation and analysis of the basic situation of nuclear medicine in Beijing in 2019

Objective To have a comprehensive knowledge of the development status of nuclear medicine in medical institutions in Beijing so as to provide data for national authorities that they can use in allocating medical resources and formulating medical policies. Methods In 2019, medical units in Beijing with departments related to nuclear medicine were surveyed via questionnaires. The questionnaires were distributed via email or on-site submission. The contents of the questionnaire included general information on medical institution, business setting, scale of installation of imaging equipment, staff information, diagnosis and treatment workload, information on license to use radiopharmaceuticals, and teaching and scientific research workload. Results A total of 39 medical units were found to be engaged in nuclear medicine in Beijing, most of which were in tertiary hospitals (87.2%, 34/39). In these units, a total of 40 departments were related to nuclear medicine, one of which had an independent nuclear medicine department and an independent PET/CT center. The size of the entire nuclear medicine departments in Beijing was 35 000 m2. These departments had 596 staff but few nuclear medicine physicists and radiochemists. Among the 40 departments, 30 (75.0%) provided outpatient service, 28 (70.0%) performed radionuclide therapy, 37 (92.5%) offered single photon imaging, and 16 (40.0%) conducted positron imaging. Collectively, these departments had 83 pieces of large-scale nuclear medicine imaging equipment, including 21 PET/CT machines. In 2019, these departments performed 232 838 imaging cases and 7760 therapy cases, of which 28 medical units administered radionuclide therapy. However, the number of conventional radionuclide imaging projects and radionuclide treatment projects that these departments collectively conducted were relatively few. All 40 departments had a license to use radiopharmaceuticals, of which 5 departments had a license to use class Ⅳ radiopharmaceuticals (12.5%). These departments had 12 standardized training bases for nuclear medicine residents in Beijing and 106 ongoing projects, 29 departments had teaching tasks. Conclusions The nuclear medicine department system in Beijing has taken shape. Planning and management have achieved initial results, but the training of professional talents must be strengthened further. Moreover, the development and clinical transformation of innovative radiopharmaceuticals must be promoted and developed.